U.S. Markets close in 3 hrs 6 mins
Stocks to Watch

Abercrombie & Fitch soars, GM expects Cadillac boost, Barnes and Noble may go private

AstraZeneca's MedImmune unit acquires AlphaCore Pharma

AstraZeneca announced that MedImmune, its global biologics research and development unit, has acquired AlphaCore Pharma, an Ann Arbor, Michigan-based biotechnology company focused on the development of ACP-501, a recombinant human lecithin-cholesterol acyltransferase enzyme. Financial details of the acquisition were not disclosed.